Kilitch Drugs (India) Ltd Share Price (KILITCH)
Check the latest share price of Kilitch Drugs (India) Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Kilitch Drugs (India) Ltd Stock Performance
Get live Kilitch Drugs (India) Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹433.3Day's Price Range₹459.952 Week's Low
52 Week's High
₹299.9552-Week Price Range₹499
| Returns % | |
| 1 Month Return | + 8.84 % |
| 3 Month Return | + 41.61 % |
| 1 Year Return | + 37.27 % |
| 3 Year Return | + 183.18 % |
| 5 Year Return | + 293.51 % |
| Market Stats | |
| Previous Close | ₹454.55 |
| Open | ₹440.00 |
| Volume | 10.07K |
| Upper Circuit | ₹477.25 |
| Lower Circuit | ₹431.85 |
Kilitch Drugs (India) Ltd Fundamentals & Key Indicators
Check Kilitch Drugs (India) Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹730.94 Cr
Return on Equity (ROE)
8.39
PE Ratio (TTM)
27.76
Return on capital employed (ROCE)
10.74
Industry PE ratio
57.39
Beta (LTM)
0.82
P/B Ratio
2.81
Dividend Yield
0PEG Ratio
3.86
Quarterly Earnings Growth YOY
177.72
EPS (TTM)
8.44
Sector
Pharmaceuticals
Book Value
109.62
Technical Analysis
Bullish
View Technical Analysis
How to invest in Kilitch Drugs (India) Ltd?
Investing in Kilitch Drugs (India) Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Kilitch Drugs (India) Ltd or KILITCH on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Kilitch Drugs (India) Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Kilitch Drugs (India) Ltd with just a few clicks!
Kilitch Drugs (India) Ltd Stock's Interest Amongst Investors
Kilitch Drugs (India) Ltd Valuation
Track how Kilitch Drugs (India) Ltd P/E has moved over time to understand its valuation trends.
Kilitch Drugs (India) Ltd in the last 5 years
Lowest (-986.00x)
July 3, 2019
Today (27.76x)
June 13, 2025
Industry (57.39x)
June 13, 2025
Highest (363.79x)
October 16, 2020
Today’s Price to Earnings Ratio: 27.76x
Kilitch Drugs (India) Ltd Financial Results
Get the annual and quarterly financial summary of Kilitch Drugs (India) Ltd, including revenue, profit, loss and more.
Kilitch Drugs (India) Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Kilitch Drugs (India) Ltd.
Kilitch Drugs (India) Ltd Earnings Results
Kilitch Drugs (India) Ltd’s net profit jumped 189.69% since last year same period to ₹10.40Cr in the Q4 2024-2025. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated 74.5% jump in its net profits since last 3-months.
Read More about Earnings ResultsKilitch Drugs (India) Ltd Dividends May,2019
In the quarter ending March 2019, Kilitch Drugs (India) Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.11%.
Read More about Dividends
Kilitch Drugs (India) Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Kilitch Drugs (India) Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 69.23% | 0.00 | |
| Foreign Institutions | 0% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 30.77% | 0.00 | |
| Others | 0% | 0.00 |
Kilitch Drugs (India) Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Kilitch Drugs (India) Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 730.94 | 58.7% | 0.56 | 13 | 154 | |
| NA | 6.24 | 5.19% | 5.69 | NA | NA | |
| NA | 81.58 | 58.65% | 0.51 | 1 | 40 | |
| NA | 1,949.06 | 25.81% | 0.51 | 58 | 630 | |
| NA | 69.91 | 6.88% | 0.78 | 2 | 45 |
Kilitch Drugs (India) Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Kilitch Drugs (India) Ltd.
Kilitch Drugs Reports Strong Financial Growth - 20 May, 2025
Kilitch Drugs reported a 36.61% increase in net sales to Rs 61.23 crore for March 2025, with net profit soaring 189.34% to Rs 10.40 crore. EBITDA rose 115.89%, and EPS increased to Rs 6.47. The stock has delivered significant returns of 40.20% over six months and 27.72% over twelve months.
Insights on Kilitch Drugs (India) Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 5.96 Cr → 10.4 Cr (in ₹), with an average increase of 42.7% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 36.03 Cr → 62.92 Cr (in ₹), with an average increase of 16.2% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, KILITCH has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Price Rise
In the last 6 months, KILITCH stock has moved up by 40.0%
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 69.23% of holdings in Mar 2025 quarter
- NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 30.77% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 8.0%
About Kilitch Drugs (India) Ltd
Revenue: ₹61.23Cr as on March 2025 (Q4 FY25)
Net Profit: ₹10.22Cr as on March 2025 (Q4 FY25)
Listing date: 29 Sep, 2010
Chairperson Name: Mukund P Mehta
| Organisation | Kilitch Drugs (India) Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Mukund P Mehta |
| E-voting on shares | Click here to vote |
FAQs
What is Kilitch Drugs (India) Ltd share price today?
Kilitch Drugs (India) Ltd share price today stands at ₹454.5, Open: ₹440, Previous Close: ₹454.55, High: ₹459.9, Low: ₹433.3, 52 Week High: ₹499, 52 Week Low: ₹299.95.
What is today's traded volume of Kilitch Drugs (India) Ltd?
Today's traded volume of Kilitch Drugs (India) Ltd is 10.07K. Which means that 10.07K shares of Kilitch Drugs (India) Ltd were bought and sold on the stock market during today's trading session.
What is Kilitch Drugs (India) Ltd's market cap today?
Today's market capitalisation of Kilitch Drugs (India) Ltd is ₹730.94 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Kilitch Drugs (India) Ltd?
Kilitch Drugs (India) Ltd’s 52 week high is ₹499 and 52 week low is ₹299.95. The current share price of Kilitch Drugs (India) Ltd is ₹454.5, which is -8.92% down from its 52 week high and 51.53% up from its 52 week low.